- Home
- ASTI vs NLSP Comparison
ASTI vs NLSP Comparison
Compare ASTI & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- NLSP
- Stock Information
- Founded
- ASTI 2005
- NLSP 2015
- Country
- ASTI United States
- NLSP Switzerland
- Employees
- ASTI N/A
- NLSP N/A
- Industry
- ASTI Semiconductors
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- NLSP Health Care
- Exchange
- ASTI Nasdaq
- NLSP Nasdaq
- Market Cap
- ASTI 2.8M
- NLSP 243.8M
- IPO Year
- ASTI N/A
- NLSP 2021
- Fundamental
- Price
- ASTI $2.61
- NLSP $5.18
- Analyst Decision
- ASTI
- NLSP
- Analyst Count
- ASTI 0
- NLSP 0
- Target Price
- ASTI N/A
- NLSP N/A
- AVG Volume (30 Days)
- ASTI 49.8K
- NLSP 36.1K
- Earning Date
- ASTI 11-12-2024
- NLSP 10-25-2024
- Dividend Yield
- ASTI N/A
- NLSP N/A
- EPS Growth
- ASTI N/A
- NLSP N/A
- EPS
- ASTI N/A
- NLSP N/A
- Revenue
- ASTI $266,077.00
- NLSP N/A
- Revenue This Year
- ASTI N/A
- NLSP N/A
- Revenue Next Year
- ASTI N/A
- NLSP N/A
- P/E Ratio
- ASTI N/A
- NLSP N/A
- Revenue Growth
- ASTI 8.81
- NLSP N/A
- 52 Week Low
- ASTI $2.25
- NLSP $4.08
- 52 Week High
- ASTI $198.00
- NLSP $31.60
- Technical
- Relative Strength Index (RSI)
- ASTI 43.34
- NLSP 49.17
- Support Level
- ASTI $2.35
- NLSP $4.38
- Resistance Level
- ASTI $2.84
- NLSP $5.36
- Average True Range (ATR)
- ASTI 0.21
- NLSP 0.44
- MACD
- ASTI 0.09
- NLSP 0.07
- Stochastic Oscillator
- ASTI 50.98
- NLSP 77.14
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.